Albert Bourla
Chairman of the Board & CEODr. Albert Bourla, DVM, Ph.D. serves as Chairman & CEO at Pfizer Venture Investments LLC. He serves as CEO from January 2019. He serves as the Chief Executive Officer of Pfizer Inc. since January 1, 2019 and serves as its Chairman and director of the Board since January 2020 and had been its Executive Director since February 23, 2018 until January 2020. Dr. Bourla serves as a Co-Chair at The Partnership for New York City, Inc. Dr. Bourla was Chief Operating Officer of Pfizer Inc. since January 2018 until December 2018. Dr. Bourla had been Chairman of the Board at Pfizer Inc. since January 1, 2020 until 2023. Dr. Bourla served as Group President of Pfizer Innovative Health at Pfizer Inc. since June 2016 until December 2017. He served as Group President of Global Innovative Pharma & Global Vaccines, Oncology & Consumer Healthcare Businesses at Pfizer Inc. since February 12, 2016 until June 2016. Dr. Bourla served as Group President of the Vaccines, Oncology and Consumer Healthcare Business at Pfizer Inc. since January 1, 2014. Dr. Bourla served as President and General Manager of Established Products Business Unit at Pfizer Inc. from December 2010 to December 2013 and served as its Area President of Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 to November 2010 and Area President of Europe, Africa and Middle East of Pfizer Animal Health from 2005 to 2009. He is Board member of Pharmaceutical Research and Manufacturers of America (PhRMA), Board member of The Pfizer Foundation and Member of the Board of the Partnership for New York City and Catalyst. Over the course of his career. Dr. Bourla has held a number of senior global positions across a range of businesses and geographies. Dr. Bourla has significant scientific expertise. He is a Doctor of Veterinary Medicine and holds a PhD degree in the Biotechnology of Reproduction from the Veterinary School of Aristotle University.
公司职务
- 公司名称Pfizer Inc.股票代码PFE职务Chairman of the Board & CEO共事同僚
- CBChris BoshoffChief Scientific Officer and President of Research & Development
- DMDouglas M. LanklerExecutive VP & Chief Legal Officer
- AMAamir MalikExecutive VP & Chief U.S. Commercial Officer
- CGCecile GueganExecutive VP & CFO
- SMSuzanne M. Nora JohnsonIndependent Director
- JCJames C. SmithIndependent Director
- JJJoseph J. EchevarriaIndependent Director
- SGScott GottliebIndependent Director
